TDC
OMCL icon

Thompson Davis & Co’s Omnicell OMCL Stock Holding History

Thompson Davis & Co’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-500
Closed -$24K – 691
2017
Q4 		$24K Sell
500
-300
-38% -$15.1K 0.06% 296
2017
Q3 		$41K Buy
800
+475
+146% +$22.8K 0.07% 282
2017
Q2 		$14K Buy
+325
New +$13.5K 0.02% 569

Other funds holding OMCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Thompson Davis & Co's OMCL Position: Q1 2018 in Review

Thompson Davis & Co sold out of Omnicell (OMCL) in Q1 2018, closing a stake of 500 shares — an estimated $24K sold.

Thompson Davis & Co first reported a position in OMCL in Q2 2017 and held it in 3 quarters. The position peaked at $41K in Q3 2017. 231 funds tracked by Wall St. Rank hold OMCL as of Q1 2018.

  • Thompson Davis & Co reported no remaining Omnicell position as of Q1 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 500 Omnicell shares in Q1 2018, an estimated $24K.
  • Thompson Davis & Co first reported a position in Omnicell in Q2 2017 and held it in 3 quarters.
  • Thompson Davis & Co's Omnicell position peaked at $41K in Q3 2017.
  • 231 funds tracked by Wall St. Rank held Omnicell as of Q1 2018.

Based on Thompson Davis & Co's 13F filing for Q1 2018, filed 2 May 2018.